KAREN MEYER-HOWE: Open Payments
NPI 1609896836 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 28 payments from 7 companies in 2025. Trend: 2023 $1,401 · 2024 $1,305 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $458 |
| Medtronic, Inc. | 1 | $186 |
| Sequel Med Tech, LLC | 1 | $146 |
| Insulet Corporation | 1 | $125 |
| Lilly USA, LLC | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $16 |
Products named: Ozempic, MINIMED 780G, TWIIST, OMNIPOD, MOUNJARO, Wegovy, GVOKE HYPOPEN, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
